In pharma, the right contact is rarely the obvious one. When a company wants to talk about pricing, reimbursement or access to a market, it needs the people who run pharma market access, not the general inbox or the press office. This case study shows how our team found those people at Europe’s largest pharmaceutical companies.
Client names stay private, so we share the brief, the method and the delivery.
At a glance
| Market | Pharmaceutical companies, Europe |
| Companies | The top 15 by market capitalization |
| Company data | Market size and revenue for each company |
| Contacts | Emails of the key market access executives |
| Used for | Business development and networking in European pharma |
The brief
The client wanted to build relationships in the European pharmaceutical sector. They needed two things in one place: a clear list of the largest companies, and the people responsible for market access inside each of them.
Why this kind of research takes care
Market access teams in pharma sit in different places in different companies. Job titles vary as well, so a simple title search either misses people or pulls in the wrong roles. Large pharma groups also have many country offices, which makes it easy to land on someone who doesn’t own the topic.
That is why this work needs researchers, not just a database export. The first job is deciding which companies are in scope. The second is finding the right people inside each one.
What we did
We started with the companies. Our researchers identified the top 15 pharmaceutical companies in Europe based on market capitalization, and recorded each company’s market size and revenue.
Then we moved to the people. For each company, the team gathered the contact information of the individuals responsible for market access, including their emails.
What the client received
A concise list and report with:
- Europe’s 15 largest pharmaceutical companies by market capitalization
- the market size and revenue of each company
- the emails of the key market access executives at each company
What this means for your campaign
When your buyers sit inside a few very large organizations, a list of 15 well-chosen companies can be worth more than a list of thousands. The value is in knowing exactly who owns the decision.
We take the same approach in other complex markets: first the right companies, then the right people inside them. See how our B2B lead generation services work, or start with market research if you need to size the market first.




